3M just posted its fifth consecutive earnings beat and raised full-year guidance, but lingering litigation risks and a divided analyst camp raise a real question about whether the rally has legs or is running…
Tesla is bleeding year-to-date losses while Google shrugs off a 46% free cash flow collapse, yet both Magnificent Seven giants share the same bold 2027 price target gap. The catalysts that close it are…
NFLX has shed nearly half its value in a year, sentiment has cratered, and prediction markets give it little chance of holding $70 this week. So why is one analyst reaching for the buy…
Arm Holdings has staged one of the sharpest re-ratings in large-cap tech this year, but a brutal pullback from its highs raises a critical question about whether the royalty model can justify a valuation…
Bloom Energy has turned into one of 2026's most explosive trades, but a short seller report and a 25% pullback in a single month have exposed a sharp divide between believers in the AI…
Both Meta and Pinterest crushed Q1 earnings with double-digit revenue growth, but one is spending $125 billion chasing a superintelligence future while the other just hit a billion-dollar quarter for the first time. The…
POET Technologies posted 201% revenue growth yet its stock sits near 52-week lows while class action lawsuits and a CEO exit pile on. Here is what needs to happen for shares to reach a…
Alphabet and Apple both crushed their last quarters, but they are running completely opposite playbooks heading into earnings season. One is burning through cash to own the AI future while the other hands it…
AMC just posted the strongest quarter in its 106-year history, and the stock still has Wall Street's consensus pointing the wrong direction. Here is why that contradiction tells you exactly what to do next.
JNJ is pruning its portfolio while Abbott just dropped $21 billion to expand into cancer diagnostics, and the two strategies are pulling their stocks in completely opposite directions. Which move looks smarter when you…
Credo Technology's revenue tripled and its stock soared over 1,600% in five years, yet shares just cratered 21% in a single week. Here is what that sell-off reveals about whether a $350 price target…
Tesla sits dead last among the Magnificent 7 in 2026, weighed down by inventory creep, collapsing energy revenue, and a valuation that makes even bulls sweat. But Q2 earnings could rewrite the narrative entirely,…
CoreWeave's shares have cratered over 40% in the past year while its business is booking record revenue and a backlog nearing $100 billion, and that contradiction creates one of the most contested trades in…
Joby Aviation shares have collapsed nearly 58% over the past year, yet the company just raised over a billion dollars and is days away from launching paid passenger flights in Dubai. Whether that momentum…
Rambus just shed nearly 30% from its June peak while two major Wall Street firms initiated coverage with aggressive buy ratings. Before the July 27 earnings report arrives, here is what the disconnect reveals…
Ray Dalio's Bridgewater holds major stakes in Amazon, NVIDIA, and Alphabet, but one of the three flashes a warning sign that could reshape the entire investment case before year-end.
Nvidia just posted 85% revenue growth and raised its buyback to $80 billion, yet the stock sits 28% below its 52-week high and Wall Street is split on whether the AI trade has legs.…
Microsoft sits 37% below the price needed to reclaim the $4 trillion club, yet Wall Street is nearly unanimously bullish and one key date could change everything for patient shareholders.
Costco, Fastenal, and Visa all pass Warren Buffett's classic quality screen, but passing the quality test and clearing the valuation bar are two very different things. One of these compounders is a trap at…
Palantir bears have called the stock overvalued at every step, yet the company keeps silencing them with results that strain credibility. After eight straight earnings beats and a dramatic guidance raise, our model lands…
